Top Tweets for #DiscoverForPatients
We are pleased to announce our Q3 2024 financial results and corporate update. For more details, read the full update here: https://t.co/5f2T3cXTyH
#RyvuTx #DiscoverForPatients #CorporateUpdate #FinancialResults #Q32024
The 2024 EORTC-NCI-AACR Symposium (ENA) in Barcelona is just around the corner! This year, we’re thrilled to present our progress on RVU120, RVU305, and other synthetic lethality projects. Join us in Barcelona!
#RyvuTx #DiscoverForPatients #ENASymposium2024
We're gearing up for the 2024 EORTC-NCI-AACR Symposium in Barcelona! This time, we will present clinical and preclinical data on several programs!
Learn more: https://t.co/WGZAQ9hk9d
#DiscoverForPatients #EORTC #SyntheticLethality #RVU120 #RVU305 #ONCOPrime #WRN #PRMT5
We are delighted to share our H1 2024 financial results and corporate update. Read more: https://t.co/FvqGU6G6Ml
#RyvuTx #DiscoverForPatients #CorporateUpdate #FinancialResults #H12024
Najnowsze dane dotyczące efektywności w modelach zwłóknienia szpiku kostnego (MF) znacząco rozszerzają możliwości terapeutycznego zastosowania RVU120 u pacjentów z MF. Ryvu planuje rozpoczęcie badania POTAMI-61. #DiscoverForPatients #EHA2024 #MF #RVU120
Badanie fazy II RVU120 - RIVIER-52 we wskazaniu AML i HR-MDS trwa od kilku miesięcy. Szczegółowe wyniki badania na konferencji EHA2024 przedstawił lek. Dominik Chraniuk. Więcej: https://t.co/O9yaaMbV6S
#DiscoverForPatients #EHA2024 #AML #RVU120
"Hello and dzień dobry!" At the last #EHA2024 Conference, we had an excellent opportunity to discuss the progress in research on RVU120. Tune in to Hendrik's insights from the event.
https://t.co/61U3NjnmsJ #DiscoverForPatients #hematology
Another busy day at #EHA2024 is drawing to a close. We are delighted to be here, showcasing our scientific accomplishments. Our day began with a webinar and will conclude with a poster presentation. See you there!
#Ryvers #DiscoverForPatients
We're excited to announce our participation in the upcoming #EHA2024 Congress! Visit us at stand number F05, where our team will be available to discuss our projects and latest achievements.
#RVU120 #DiscoverForPatients
Ryvu will attend the prestigious BIO International Convention from June 3 to 6! You can find us at the Polish International booth #4049.
#BIO2024 #Ryvu #DiscoverForPatients
Our Chief Business Officer, Vatnak Vat-Ho, will participate in the 10th Annual Oncology Innovation Forum and ASCO 2024 from May 31st to June 3rd. Join him!
#Ryvu #DiscoverForPatients #ASCO2024 #OncologyInnovation #PharmaBiotech
We are delighted to share our Q1 financial results and corporate update.
Read more: https://t.co/YtshIsGuBI
#RyvuTx #DiscoverForPatients #CorporateUpdate #FinancialResults #Q12024
Ryvu Therapeutics is gearing up to showcase updated data on RVU120 at the 2024 European Hematology Association (EHA) Congress in Spain.
Read more: https://t.co/Bb6MCn6L7T
#RVU120 #DiscoverForPatients #EHA2024 #Hematology #CancerResearch #MedicalInnovation
Zobacz tłumaczenie
Wyjątkowy wywiad! O życiowych wyborach, pasjach i szeroko pojętym biznesie, bez lukru, z Pawłem Przewięźlikowskim rozmawiał Tomek Plata. Zapraszamy: https://t.co/EO576I85AT
#RyvuTx #DiscoverForPatients #BiznesBezLukru
The AACR 2024 is underway, and we are here on-site to present progress in our oncology pipeline!
Read more: https://t.co/6p6SGO2YYT
See the scientific posters: https://t.co/Heq2yJHCc8
#AACR2024 #AACRAnnualMeeting #RyvuTherapeutics #CancerResearch
#DiscoverForPatients
Only one day left for the 2024 AACR Annual Meeting in San Diego, USA. Ryvu Therapeutics is preparing to share the most recent findings from our research and development programs.
Read more about our abstracts: https://t.co/ZxNn6qZDHV
#AACR2024 #DiscoverForPatients
We are thrilled to announce the disbursement of the first tranche of EUR 8 million venture debt from the European Investment Bank (EIB).
Find out more: https://t.co/HNG4ZJzJnO
#RyvuTherapeutics #InnovationInOncology #FundingBoost #EIBFunding #DiscoverForPatients
Last week, we enjoyed engaging with the #hematology community at the inspiring #ASH23 and appreciate your participation in our poster presentations. From now on, you can download all posters from our website:
https://t.co/WxDdc81PJp
#DiscoverForPatients #RVU120
#SABCS2023 is underway. Learn more about compelling translational data on RVU120 in combination with MEK inhibitors for hormone receptor-negative breast cancer - a subtype known for its treatment challenges.
https://t.co/9wzYfLTN7S
#RVU120 #DiscoverForPatients
Last Seen Hashtags on Sotwe
bokepindo
Seen from Indonesia
izmirgay
Seen from Turkey
snapchat
Seen from Ireland
public milf
Seen from Canada
SharonMitchell
Seen from United Kingdom
momson to do.
Seen from United States
teenageeer
milliebobbybrown goon
Seen from United States
短丝
Seen from United States
ตัดต่อดารา
Seen from Thailand
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
118.8M followers
Cristiano Ronaldo
@cristiano
114.5M followers
Donald J. Trump
@realdonaldtrump
111.9M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.4M followers
Kim Kardashian
@kimkardashian
70.8M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.2M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.7M followers
X
@x
60.7M followers